Puma Biotechnology Stock Soars on Breast Cancer Sales Beat

Several analysts have already raised their price targets on PBYI

Digital Content Manager
Mar 1, 2019 at 9:57 AM
facebook X logo linkedin

The shares of Puma Biotechnology Inc (NASDAQ:PBYI) are up 40% at $39.10 in early trading, after the drugmaker announced better-than-expected revenue for the fourth quarter. The company also reported sales of its breast cancer drug, Nerlynx, that beat analysts' expectations. The stock is now pacing for its best day since July 2014. 

Today's pop could close PBYI's Nov. 2 bear gap, too -- a drop that caused the equity to hit a six-year low of $17.60. The stock has since more than doubled, and today could take out its 200-day moving average for the first time since early 2018. 

In the wake of Puma's rally, several analysts have already raised their price targets, including Cantor Fitzgerald (to $57), J.P. Morgan Securities (to $27), and RBC (to $37). The consensus 12-month target price of $40 is just a stone's throw from current levels, suggesting more price-target hikes could ensue. Plus, prior to today, six of the eight analysts following the pharma name issued a "hold" or worse rating, which could leave the door open for upgrades. 

PBYI stock could enjoy some additional tailwinds as option bears begin to hit the exits, too. On the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock sports a 10-day put/call volume ratio of 1.02 that sits in the 88th percentile of its annual range. This means that in the past two weeks, puts were bought over calls at a much faster pace than what is typically seen.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI